152 related articles for article (PubMed ID: 22759323)
1. Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate.
Manfredi M; Bizzarri B; de'Angelis GL
Helicobacter; 2012 Aug; 17(4):246-53. PubMed ID: 22759323
[TBL] [Abstract][Full Text] [Related]
2. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori.
Polat Z; Kadayifci A; Kantarcioglu M; Ozcan A; Emer O; Uygun A
Eur J Intern Med; 2012 Mar; 23(2):165-8. PubMed ID: 22284248
[TBL] [Abstract][Full Text] [Related]
3. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study.
Calhan T; Kahraman R; Sahin A; Senates E; Doganay HL; Kanat E; Ozdil K; Sokmen HM
Helicobacter; 2013 Oct; 18(5):378-83. PubMed ID: 23601026
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
Molina-Infante J; Perez-Gallardo B; Fernandez-Bermejo M; Hernandez-Alonso M; Vinagre G; Dueñas C; Mateos-Rodriguez JM; Gonzalez-Garcia G; Abadia EG; Gisbert JP
Aliment Pharmacol Ther; 2010 May; 31(10):1077-84. PubMed ID: 20180787
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
[TBL] [Abstract][Full Text] [Related]
7. Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
Gisbert JP; Pérez-Aisa A; Bermejo F; Castro-Fernández M; Almela P; Barrio J; Cosme A; Modolell I; Bory F; Fernández-Bermejo M; Rodrigo L; Ortuño J; Sánchez-Pobre P; Khorrami S; Franco A; Tomas A; Guerra I; Lamas E; Ponce J; Calvet X;
J Clin Gastroenterol; 2013 Feb; 47(2):130-5. PubMed ID: 22647827
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Pontone S; Standoli M; Angelini R; Pontone P
Dig Liver Dis; 2010 Aug; 42(8):541-3. PubMed ID: 20061196
[TBL] [Abstract][Full Text] [Related]
9. Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer.
Ermis F; Akyuz F; Uyanikoglu A; Kurt R; Pinarbasi B; Nazik H; Kaymakoglu S; Mungan Z
South Med J; 2011 Aug; 104(8):579-83. PubMed ID: 21886067
[TBL] [Abstract][Full Text] [Related]
10. [Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study].
Cheng H; Hu FL; Zhang GX; Shi RH; Du YQ; Li ZS; Han W; Li YQ; Wu QD; Qian KD
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):79-82. PubMed ID: 20356486
[TBL] [Abstract][Full Text] [Related]
11. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.
Romano M; Cuomo A; Gravina AG; Miranda A; Iovene MR; Tiso A; Sica M; Rocco A; Salerno R; Marmo R; Federico A; Nardone G
Gut; 2010 Nov; 59(11):1465-70. PubMed ID: 20947881
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Manes G; Efrati C; Hassan C; Maconi G; Piglionica D; Cannaviello C; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2007 Sep; 39(9):806-10. PubMed ID: 17644057
[TBL] [Abstract][Full Text] [Related]
13. Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice.
Zullo A; De Francesco V; Manes G; Scaccianoce G; Cristofari F; Hassan C
J Gastrointestin Liver Dis; 2010 Jun; 19(2):131-4. PubMed ID: 20593044
[TBL] [Abstract][Full Text] [Related]
14. Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China.
Qian J; Ye F; Zhang J; Yang YM; Tu HM; Jiang Q; Shang L; Pan XL; Shi RH; Zhang GX
Helicobacter; 2012 Dec; 17(6):478-85. PubMed ID: 23067317
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection.
Tursi A; Picchio M; Elisei W
J Gastrointestin Liver Dis; 2012 Jun; 21(2):133-8. PubMed ID: 22720300
[TBL] [Abstract][Full Text] [Related]
16. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
[TBL] [Abstract][Full Text] [Related]
17. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
18. High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.
Cammarota G; Martino A; Pirozzi G; Cianci R; Branca G; Nista EC; Cazzato A; Cannizzaro O; Miele L; Grieco A; Gasbarrini A; Gasbarrini G
Aliment Pharmacol Ther; 2004 Apr; 19(7):789-95. PubMed ID: 15043520
[TBL] [Abstract][Full Text] [Related]
19. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
20. 'Rescue' therapies for the management of Helicobacter pylori infection.
Di Mario F; Cavallaro LG; Scarpignato C
Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
